TAERA MULDER: Open Payments
NPI 1821283870 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$449 in 6 payments from 5 companies in 2025. Trend: 2023 $394 · 2024 $346 · 2025 $449
Food & beverage: $449
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 1 | $127 |
| Calliditas Therapeutics US Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $74 |
| Travere Therapeutics, Inc. | 2 | $63 |
| Novartis Pharmaceuticals Corporation | 1 | $61 |
Products named: TZIELD, TARPEYO, LOKELMA, Vanrafia.
Industry payments across IA — which companies pay providers there.
